From refractory cancer to various indications

Pipeline
Pipeline
  • HOME
    • >
  • Pipeline
DAWONMEDAX is also building pipelines for two indications: glioblastoma and head and neck cancer, the highest-level brain tumors.

DAWONMEDAX strives to implement innovative clinical application of BNCT, and is planning to scale up for securing opportunities to patients who need new treatments. We are planning clinical development to scale up clinical indications for breast cancer, malignant melanoma and skin cancer, anal and rectal cancer, malignant mesothelioma, multiple lung cancer and liver cancer. With open innovation, the next-generation boron drug pipeline will be built up to scale up the indications of various target diseases.

  • Indications
  • Non-clinical
  • Phase I
  • Phase II
  • Recurrent glioblastoma
  • Locally recurrent head and neck cancer